Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting β2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback